Portfolio Holdings Detail for ISIN IE000X08RX14
| Stock Name / Fund | iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | EDMNZx(NZD) CXE |
Holdings detail for INCY
| Stock Name | Incyte Corporation |
| Ticker | INCY(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US45337C1027 |
| LEI | 549300Z4WN6JVZ3T4680 |
Show aggregate INCY holdings
News associated with INCY
- JPMorgan Chase & Co. Issues Pessimistic Forecast for Incyte (NASDAQ:INCY) Stock Price
- Incyte (NASDAQ:INCY – Get Free Report) had its price target lowered by analysts at JPMorgan Chase & Co. from $70.00 to $68.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of […] - 2025-04-23 05:42:49
- Incyte Earnings Preview: What to Expect
- Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth. - 2025-04-16 17:41:38
- Incyte Earnings Preview: What to Expect
- Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth. - 2025-04-16 13:55:44
- Franklin Resources Inc. Acquires 143,059 Shares of Incyte Co. (NASDAQ:INCY)
- Franklin Resources Inc. lifted its stake in Incyte Co. (NASDAQ:INCY – Free Report) by 70.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 344,777 shares of the biopharmaceutical company’s stock after purchasing an additional 143,059 shares during the period. Franklin Resources Inc.’s holdings in Incyte were worth $23,814,000 as of its most recent […] - 2025-04-07 08:40:56
- Incyte Stock: Is INCY Outperforming the Health Care Sector?
- Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-04-01 15:55:45
- Incyte Co. (NASDAQ:INCY) Shares Bought by Corient Private Wealth LLC
- Corient Private Wealth LLC lifted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 3.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,577 shares of the biopharmaceutical company’s stock after buying an additional 979 shares during the period. Corient Private Wealth LLC’s holdings […] - 2025-03-25 08:36:52
- Incyte (NASDAQ:INCY) Rating Lowered to “Market Perform” at William Blair
- Incyte (NASDAQ:INCY – Get Free Report) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Marketbeat.com reports. William Blair also issued estimates for Incyte’s FY2025 earnings at $4.21 EPS. Several other brokerages have also recently issued reports on INCY. Wells Fargo & […] - 2025-03-20 06:28:53
- Stocks Settle Lower as Megacap Tech Stocks Routed
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.66%. March E-mini S&P futures (ESH25 ) are down -1.06%, and March E-mini Nasdaq futures... - 2025-03-19 14:00:55
- Truist Financial Cuts Incyte (NASDAQ:INCY) Price Target to $72.00
- Incyte (NASDAQ:INCY – Free Report) had its price target reduced by Truist Financial from $74.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have a hold rating on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. Guggenheim lowered shares of Incyte from a “buy” rating […] - 2025-03-19 07:48:48
- Incyte (NASDAQ:INCY) Stock Rating Lowered by Guggenheim
- Guggenheim lowered shares of Incyte (NASDAQ:INCY – Free Report) from a buy rating to a neutral rating in a report issued on Tuesday, Marketbeat Ratings reports. They currently have $92.00 price objective on the biopharmaceutical company’s stock. Several other brokerages have also recently issued reports on INCY. Citigroup reduced their price target on shares of […] - 2025-03-19 06:47:05
- Stocks Retreat on Weakness in Technology Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. March E-mini S&P futures (ESH25 ) are down -1.29%, and March E-mini Nasdaq futures... - 2025-03-18 20:56:31
- Stocks Slide on Economic Growth Concerns
- The S&P 500 Index ($SPX ) (SPY ) today is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.73%. March E-mini S&P futures (ESH25 ) are down -0.96%, and March E-mini Nasdaq futures... - 2025-03-18 20:52:02
- Stocks Settle Higher on a Broad-Based Rally
- The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.85%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.55%. March E-mini S&P futures (ESH25 ) are up +0.66%, and March E-mini Nasdaq futures... - 2025-03-18 13:36:27
- Stocks Turn Mixed as Magnificent Seven Stocks Fall
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. March E-mini S&P futures (ESH25 ) are up +0.16%, and March E-mini Nasdaq futures... - 2025-03-17 23:40:58
- Stocks Supported by Strength in Chip Stocks and Lower Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.41%. March E-mini S&P futures (ESH25 ) are up +0.51%, and March E-mini Nasdaq futures... - 2025-03-17 21:11:45
- Is Regeneron Pharmaceuticals Stock Underperforming the Dow?
- Regeneron Pharmaceuticals has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects. - 2025-03-06 18:56:03
- Bank of New York Mellon Corp Increases Holdings in Incyte Co. (NASDAQ:INCY)
- Bank of New York Mellon Corp boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,127,515 shares of the biopharmaceutical company’s stock after buying an additional […] - 2025-03-04 09:51:06
- IFP Advisors Inc Sells 372 Shares of Incyte Co. (NASDAQ:INCY)
- IFP Advisors Inc trimmed its position in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 12.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,532 shares of the biopharmaceutical company’s stock after selling 372 shares during the period. IFP Advisors Inc’s holdings […] - 2025-03-04 09:14:52
- New York State Common Retirement Fund Trims Holdings in Incyte Co. (NASDAQ:INCY)
- New York State Common Retirement Fund cut its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 6.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 80,641 shares of the biopharmaceutical company’s stock after selling 5,500 shares during the period. New […] - 2025-02-28 09:04:57
- Principal Financial Group Inc. Sells 8,222 Shares of Incyte Co. (NASDAQ:INCY)
- Principal Financial Group Inc. reduced its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 212,528 shares of the biopharmaceutical company’s stock after selling 8,222 shares during the period. Principal Financial Group […] - 2025-02-27 08:30:52
- Sanctuary Advisors LLC Acquires 6,274 Shares of Incyte Co. (NASDAQ:INCY)
- Sanctuary Advisors LLC increased its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 29.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 27,330 shares of the biopharmaceutical company’s stock after buying an additional 6,274 shares during the quarter. […] - 2025-02-24 08:51:05
- Incyte Co. (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
- Vontobel Holding Ltd. reduced its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 23.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,467 shares of the biopharmaceutical company’s stock after selling 2,944 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $654,000 at the end of the […] - 2025-02-20 09:48:52
- Asset Management One Co. Ltd. Purchases 397 Shares of Incyte Co. (NASDAQ:INCY)
- Asset Management One Co. Ltd. boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 89,284 shares of the biopharmaceutical company’s stock after acquiring an additional 397 shares during the quarter. Asset Management […] - 2025-02-19 10:09:02
- Are Wall Street Analysts Bullish on Incyte Stock?
- Incyte has continued to observe strong demand for Jakafi and Opzelura, leading to robust growth in sales, and analysts remain bullish on the stock’s prospects. - 2025-02-18 14:26:19
- New York State Teachers Retirement System Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY)
- New York State Teachers Retirement System reduced its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 173,577 shares of the biopharmaceutical company’s stock after selling 318 shares during the period. New York State […] - 2025-02-18 09:29:11
- Chevy Chase Trust Holdings LLC Sells 1,802 Shares of Incyte Co. (NASDAQ:INCY)
- Chevy Chase Trust Holdings LLC lowered its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 2.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 83,907 shares of the biopharmaceutical company’s stock after selling 1,802 shares during the period. Chevy Chase Trust Holdings […] - 2025-02-18 09:28:57
- Yousif Capital Management LLC Decreases Position in Incyte Co. (NASDAQ:INCY)
- Yousif Capital Management LLC trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,109 shares of the biopharmaceutical company’s stock after selling 932 shares during the […] - 2025-02-14 08:24:54
- Incyte (NASDAQ:INCY) Lowered to Buy Rating by StockNews.com
- Incyte (NASDAQ:INCY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on the company. Wells Fargo & Company lifted their target price on Incyte from […] - 2025-02-12 07:12:43
- Incyte (NASDAQ:INCY) Shares Down 8.5% After Earnings Miss
- Incyte Co. (NASDAQ:INCY – Get Free Report)’s share price dropped 8.5% during mid-day trading on Monday following a dissappointing earnings announcement. The company traded as low as $68.18 and last traded at $67.85. Approximately 470,521 shares changed hands during trading, a decline of 66% from the average daily volume of 1,386,096 shares. The stock had […] - 2025-02-12 06:14:56
- Stocks Settle Higher and Brush Aside Tariff Concerns
- The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.24%. March E-mini S&P futures (ESH25 ) rose by +0.59%, and March E-mini Nasdaq futures... - 2025-02-11 15:10:35
iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) INCY holdings
| Date | Number of INCY Shares Held | Base Market Value of INCY Shares | Local Market Value of INCY Shares | Change in INCY Shares Held | Change in INCY Base Value | Current Price per INCY Share Held | Previous Price per INCY Share Held |
|---|
| 2024-11-08 (Friday) | 3,656 | USD 304,837 | USD 304,837 | 0 | USD 3,802 | USD 83.3799 | USD 82.34 |
| 2024-11-07 (Thursday) | 3,656 | USD 301,035 | USD 301,035 | 0 | USD 5,082 | USD 82.34 | USD 80.9499 |
| 2024-11-06 (Wednesday) | 3,656 | USD 295,953 | USD 295,953 | 0 | USD 13,417 | USD 80.9499 | USD 77.2801 |
| 2024-11-05 (Tuesday) | 3,656 | USD 282,536 | USD 282,536 | 0 | USD 5,594 | USD 77.2801 | USD 75.75 |
| 2024-11-04 (Monday) | 3,656 | USD 276,942 | USD 276,942 | 0 | USD -1,389 | USD 75.75 | USD 76.1299 |
| 2024-11-01 (Friday) | 3,656 | USD 278,331 | USD 278,331 | -64 | USD 2,605 | USD 76.1299 | USD 74.1199 |
| 2024-10-31 (Thursday) | 3,720 | USD 275,726 | USD 275,726 | 0 | USD 706 | USD 74.1199 | USD 73.9301 |
| 2024-10-30 (Wednesday) | 3,720 | USD 275,020 | USD 275,020 | 0 | USD 1,228 | USD 73.9301 | USD 73.6 |
| 2024-10-29 (Tuesday) | 3,720 | USD 273,792 | USD 273,792 | 0 | USD 29,425 | USD 73.6 | USD 65.6901 |
| 2024-10-28 (Monday) | 3,720 | USD 244,367 | USD 244,367 | 0 | USD 2,307 | USD 65.6901 | USD 65.0699 |
| 2024-10-25 (Friday) | 3,720 | USD 242,060 | USD 242,060 | 0 | USD -633 | USD 65.0699 | USD 65.2401 |
| 2024-10-24 (Thursday) | 3,720 | USD 242,693 | USD 242,693 | 0 | USD 261 | USD 65.2401 | USD 65.1699 |
| 2024-10-23 (Wednesday) | 3,720 | USD 242,432 | USD 242,432 | 0 | USD -1,563 | USD 65.1699 | USD 65.5901 |
| 2024-10-22 (Tuesday) | 3,720 | USD 243,995 | USD 243,995 | 0 | USD 1,191 | USD 65.5901 | USD 65.2699 |
| 2024-10-21 (Monday) | 3,720 | USD 242,804 | USD 242,804 | 0 | USD -4,167 | USD 65.2699 | USD 66.3901 |
| 2024-10-18 (Friday) | 3,720 | USD 246,971 | USD 246,971 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of INCY by Blackrock for IE000X08RX14
Show aggregate share trades of INCY| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2024-11-01 | SELL | -64 | | | 76.130* | | 68.19 Profit of 4,364 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of INCY
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-05-09 | 206,029 | 0 | 351,185 | 58.7% |
| 2025-05-08 | 403,448 | 399 | 772,758 | 52.2% |
| 2025-05-07 | 249,479 | 0 | 562,167 | 44.4% |
| 2025-05-06 | 528,484 | 3,571 | 777,084 | 68.0% |
| 2025-05-05 | 252,214 | 0 | 377,271 | 66.9% |
| 2025-05-02 | 452,086 | 509 | 615,933 | 73.4% |
| 2025-05-01 | 731,917 | 257 | 920,185 | 79.5% |
| 2025-04-30 | 704,725 | 15 | 937,683 | 75.2% |
| 2025-04-29 | 535,124 | 136 | 804,527 | 66.5% |
| 2025-04-28 | 455,470 | 157 | 742,089 | 61.4% |
| 2025-04-25 | 230,220 | 269 | 426,134 | 54.0% |
| 2025-04-24 | 232,299 | 248 | 485,152 | 47.9% |
| 2025-04-23 | 343,620 | 251 | 626,913 | 54.8% |
| 2025-04-22 | 202,866 | 10 | 531,632 | 38.2% |
| 2025-04-21 | 252,885 | 51 | 728,686 | 34.7% |
| 2025-04-17 | 227,278 | 225 | 406,323 | 55.9% |
| 2025-04-16 | 279,780 | 3,078 | 411,864 | 67.9% |
| 2025-04-15 | 315,634 | 993 | 559,424 | 56.4% |
| 2025-04-14 | 476,294 | 89 | 682,107 | 69.8% |
| 2025-04-11 | 377,933 | 71 | 569,626 | 66.3% |
| 2025-04-10 | 510,209 | 963 | 1,007,664 | 50.6% |
| 2025-04-09 | 929,305 | 7,321 | 1,462,819 | 63.5% |
| 2025-04-08 | 526,031 | 194 | 869,452 | 60.5% |
| 2025-04-07 | 461,587 | 1,767 | 764,671 | 60.4% |
| 2025-04-04 | 951,614 | 535 | 1,601,494 | 59.4% |
| 2025-04-03 | 400,571 | 45 | 596,018 | 67.2% |
| 2025-04-02 | 454,596 | 103 | 651,931 | 69.7% |
| 2025-04-01 | 608,560 | 612 | 861,410 | 70.6% |
| 2025-03-31 | 309,403 | 107 | 521,235 | 59.4% |
| 2025-03-28 | 236,345 | 92 | 366,663 | 64.5% |
| 2025-03-27 | 200,348 | 0 | 385,658 | 51.9% |
| 2025-03-26 | 328,806 | 4 | 528,397 | 62.2% |
| 2025-03-25 | 301,344 | 3 | 570,715 | 52.8% |
| 2025-03-24 | 538,697 | 46 | 834,929 | 64.5% |
| 2025-03-21 | 436,964 | 41 | 833,465 | 52.4% |
| 2025-03-20 | 303,400 | 0 | 641,001 | 47.3% |
| 2025-03-19 | 314,138 | 0 | 597,926 | 52.5% |
| 2025-03-18 | 502,193 | 8,801 | 1,193,807 | 42.1% |
| 2025-03-17 | 934,709 | 33,271 | 1,897,875 | 49.3% |
| 2025-03-14 | 162,195 | 0 | 427,184 | 38.0% |
| 2025-03-13 | 138,015 | 614 | 358,487 | 38.5% |
| 2025-03-12 | 181,709 | 2,435 | 511,725 | 35.5% |
| 2025-03-11 | 224,233 | 71 | 598,951 | 37.4% |
| 2025-03-10 | 95,130 | 1,370 | 377,525 | 25.2% |
| 2025-03-07 | 226,359 | 365 | 517,621 | 43.7% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.